SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001801198-24-000033
Filing Date
2024-05-13
Accepted
2024-05-13 07:01:40
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 6-K legn-20240331.htm   iXBRL 6-K 612078
2 EX-99.1 a991earningsreleaseq12024.htm EX-99.1 131754
3 EX-99.4 pipelinechart511final.htm EX-99.4 635
9 legendlogo.jpg GRAPHIC 6967
10 pipelinechart511final001.jpg GRAPHIC 118163
  Complete submission text file 0001801198-24-000033.txt   3935203

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT legn-20240331.xsd EX-101.SCH 55663
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT legn-20240331_cal.xml EX-101.CAL 86265
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT legn-20240331_def.xml EX-101.DEF 86237
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT legn-20240331_lab.xml EX-101.LAB 383151
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT legn-20240331_pre.xml EX-101.PRE 253693
76 EXTRACTED XBRL INSTANCE DOCUMENT legn-20240331_htm.xml XML 435088
Mailing Address 2101 COTTONTAIL LANE SOMERSET NJ 08873
Business Address 2101 COTTONTAIL LANE SOMERSET NJ 08873 732-317-5050
Legend Biotech Corp (Filer) CIK: 0001801198 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39307 | Film No.: 24936834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)